Tom Šolmajer

1.7k total citations
50 papers, 1.5k citations indexed

About

Tom Šolmajer is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Tom Šolmajer has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Organic Chemistry and 9 papers in Computational Theory and Mathematics. Recurrent topics in Tom Šolmajer's work include Cancer therapeutics and mechanisms (17 papers), Synthesis and biological activity (11 papers) and Protein Structure and Dynamics (9 papers). Tom Šolmajer is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Synthesis and biological activity (11 papers) and Protein Structure and Dynamics (9 papers). Tom Šolmajer collaborates with scholars based in Slovenia, France and Germany. Tom Šolmajer's co-authors include Andrej Perdih, Miha Kotnik, Matjaž Brvar, Marko Oblak, Stanislav Gobec, Gregor Anderluh, M. Renko, Gerhard Wolber, Nikola Minovski and Didier Blanot and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Tom Šolmajer

50 papers receiving 1.5k citations

Peers

Countries citing papers authored by Tom Šolmajer

Since Specialization

Citations

This map shows the geographic impact of Tom Šolmajer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Šolmajer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Šolmajer more than expected).

Fields of papers citing papers by Tom Šolmajer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Šolmajer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Šolmajer. The network helps show where Tom Šolmajer may publish in the future.

Co-authorship network of co-authors of Tom Šolmajer

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Šolmajer. A scholar is included among the top collaborators of Tom Šolmajer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Šolmajer. Tom Šolmajer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum 2018 ·Molecules ·(unknown), Andrej Perdih, Milan Senćanski, Sanja Glišić, Margarida Duarte, Ana M. Tomás, Filipa V. Sena, Filipe M. Sousa, Manuela M. Pereira, Tom Šolmajer	26
2	4,6-Substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase IIα targeting the ATP binding site 2015 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Izidor Sosič, Stanislav Gobec, Tom Šolmajer, Andrej Perdih	30
3	Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC–MurF): experimental and computational characterization 2015 ·Journal of Computer-Aided Molecular Design ·Andrej Perdih, Martina Hrast, (unknown), Hélène Barreteau, Simona Golič Grdadolnik, Darko Kocjan, Stanislav Gobec, Tom Šolmajer, Gerhard Wolber	22
4	Discovery of Mono‐ and Disubstituted 1H‐Pyrazolo[3,4]pyrimidines and 9H‐Purines as Catalytic Inhibitors of Human DNA Topoisomerase IIα 2014 ·ChemMedChem ·(unknown), Matjaž Brvar, Bojana Žegura, Metka Filipič, Tom Šolmajer, Andrej Perdih	32
5	Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIα 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Matjaž Brvar, Irena Zajc, Metka Filipič, Tom Šolmajer, Andrej Perdih	27
6	Discovery of the first inhibitors of bacterial enzyme d-aspartate ligase from Enterococcus faecium (Aslfm) 2013 ·European Journal of Medicinal Chemistry ·(unknown), Andrej Perdih, Matjaž Brvar, Ana Kroflič, (unknown), Victoria J. Savage, Alex J. O’Neill, Tom Šolmajer, Marija Bešter‐Rogač, Didier Blanot, Jean‐Emmanuel Hugonnet, Sophie Magnet, Michel Arthur, Jean‐Luc Mainardi, Jure Stojan, Anamarija Zega	19
7	Structural elucidation of transmembrane transporter protein bilitranslocase: Conformational analysis of the second transmembrane region TM2 by molecular dynamics and NMR spectroscopy 2013 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Andrej Perdih, (unknown), Emilia Sikorska, Tom Šolmajer, Stefan Jurga, Igor Zhukov, Marjana Novič	5
8	Molecular dynamics simulation and linear interaction energy study of d-Glu-based inhibitors of the MurD ligase 2013 ·Journal of Computer-Aided Molecular Design ·Andrej Perdih, Gerhard Wolber, Tom Šolmajer	24
9	Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents 2013 ·Current Pharmaceutical Design ·(unknown), Andrej Perdih, Tom Šolmajer	52
10	Cluster‐based molecular docking study for in silico identification of novel 6‐fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis 2012 ·Journal of Computational Chemistry ·Nikola Minovski, Andrej Perdih, Marjana Novič, Tom Šolmajer	17
11	Structural Analysis of a Peptide Fragment of Transmembrane Transporter Protein Bilitranslocase 2012 ·PLoS ONE ·Andrej Perdih, (unknown), (unknown), Emilia Sikorska, Igor Zhukov, Tom Šolmajer, Marjana Novič	17
12	Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment 2011 ·Journal of Molecular Modeling ·Nikola Minovski, Andrej Perdih, Tom Šolmajer	21
13	Quantitative structure–activity relationship study of antitubercular fluoroquinolones 2010 ·Molecular Diversity ·Nikola Minovski, Marjan Vračko, Tom Šolmajer	35
14	Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach 2009 ·Bioorganic & Medicinal Chemistry Letters ·Andrej Perdih, Andreja Kovač, Gerhard Wolber, Didier Blanot, Stanislav Gobec, Tom Šolmajer	63
15	Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase 2009 ·Journal of Molecular Modeling ·Andrej Perdih, Urban Bren, Tom Šolmajer	58
16	Structural and Functional Characterization of Enantiomeric Glutamic Acid Derivatives as Potential Transition State Analogue Inhibitors of MurD Ligase 2007 ·Journal of Molecular Biology ·Miha Kotnik, (unknown), Carlos Contreras‐Martel, Marko Oblak, Katja Kristan, Mireille Hervé, Didier Blanot, U. Urleb, Stanislav Gobec, Andréa Dessen, Tom Šolmajer	81
17	Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis 2006 ·Journal of Molecular Modeling ·Gregor Mlinšek, Marko Oblak, Milan Hodošček, Tom Šolmajer	3
18	Flavonoids and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: A synthesis, QSAR and modelling study 2006 ·Bioorganic & Medicinal Chemistry ·Matej Sova, Andrej Perdih, Miha Kotnik, Katja Kristan, Tea Lanišnik Rižner, Tom Šolmajer, Stanislav Gobec	39
19	Precursor of a β-lactamase inhibitor: allyl (4S,8S,9R)-10-[(E)-ethylidene]-4-methoxy-11-oxo-1-azatricyclo[7.2.0.0^3,8]undec-2-ene-2-carboxylate 2002 ·Acta Crystallographica Section C Crystal Structure Communications ·I. Leban, Lovro Selič, (unknown), (unknown), Tom Šolmajer	2
20	Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Lovro Selič, (unknown), Tom Šolmajer	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact